NWNanhui Wu

Nanhui Wu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nanhui Wu has a total of 23 co-authors. Here are the top co-authors by number of shared publications:

  • Yeqiang Liu

    Department of Dermatopathology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China

    3 shared publications
  • Fei Wu

    Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, 200443, China

    2 shared publications
  • Mingyuan Xu

    Institute of Dermatology Shanghai Skin Disease Hospital School of Medicine Tongji University Shanghai China

    2 shared publications
  • A. Zhu

    Department of Medical Ultrasound Shanghai Skin Disease Hospital Ultrasound Research and Education Institute School of Medicine Tongji University Shanghai China

    1 shared publication
  • Changchang Li

    Department of Dermatology, Wenzhou Hospital of Integrated Traditional Chinese and Western Medicine Zhejiang University of Traditional Chinese Medicine Wenzhou China

    1 shared publication
  • Dan Deng

    Department of Dermatology, Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China

    1 shared publication

Latest Publications

  • Open Access

    Effects of Citrus-derived Diosmetin on Melanoma: Induction of Apoptosis and Autophagy Mediated by PI3K/Akt/mTOR Pathway Inhibition

    by Jie Li, Mingyuan Xu, Nanhui Wu, Fei Wu, Jiashe Chen, Xiaoxiang Xu, Fei Tan, Yeqiang Liu

    Background: Diosmetin (DIOS) is a naturally abundant flavonoid and possesses various biological activities that hold promise as an anti-cancer agent. However, the anti-cancer activities and underlying mechanism of DIOS on cutaneous melanoma remain unclear. Objective: This study seeks to explore the anti-tumor effect and mechanism of DIOS in cutaneous melanoma. Methods: Here, a variety of in vitro and in vivo experiments, combined with RNA sequencing (RNA-seq), were employed to ascertain the potential anti-cutaneous melanoma capacity and mechanism of DIOS. Results: The results demonstrated that DIOS considerably impeded cell proliferation and triggered cell apoptosis in a dose- and time-dependent manner. Concurrently, DIOS markedly elevated the expression of pro-apoptotic proteins (Cleaved caspase-3, Bax, Cleaved PARP, and Cleaved caspase-9) and downregulated the expression of Bcl-2. Additionally, DIOS markedly upregulated the protein expressions of LC3B-II and Atg5, while downregulating p62 protein expression. Notably, pre-treatment with an autophagy inhibitor significantly inhibited DIOSinduced cell apoptosis and autophagy. Mechanistically, DIOS was identified to repress the PI3K/Akt/mTOR signaling pathway by western blot analyses and RNA-seq. Finally, in vivo experiments using a syngeneic mouse model confirmed the anti-tumor effect of DIOS, which exhibited high levels of apoptosis and autophagy. Conclusion: These findings propose that DIOS acts as a potential melanoma therapy that exerts its anti-tumor effects by triggering apoptosis and autophagy via inhibition of the PI3K/Akt/mTOR pathway.


  • A case of plasma cell vulvitis successfully treated with crisaborole

    by Yimin He, Mingyuan Xu, Nanhui Wu, Fei Wu, Changchang Li, Ying Gao, Yeqiang Liu


  • Value of pseudopod sign on high‐frequency ultrasound in predicting the pathological invasion of extramammary Paget's disease lesions

    by D. Shan, N. Wu, Q. Wang, W. Ren, A. Zhu, L. Wang, Y. Liu, L. Sun, L. Guo, H. Xu

    Background: Vertical invasion of extramammary Paget's disease (EMPD) is associated with poor prognosis. The usual vertical invasion route is directly downward or along the skin appendages. High‐frequency ultrasound (HFUS) can be used to measure the EMPD lesion thickness, and visualize the pseudopod extensions due to skin appendage involvement. It is a non‐invasive method for evaluating the extent of vertical invasion in EMPD.Objective: To investigate the value of HFUS in predicting the extent of vertical invasion in EMPD.Methods: In this retrospective study, 85 patients with EMPD were divided into two groups based on the pathology: invasive EMPD (iEMPD) group (n = 13) andin situEMPD group (n = 72). The clinical and HFUS features of both the groups were analysed. The different types of pseudopodia morphology on HFUS were as follows: no pseudopodia, irregular bottom, small sphere, short strip, long strip, vase shape and nodular convex. These were further stratified into low‐risk and high‐risk levels.Results: The clinical features were comparable between the two groups (P > 0.05). There were significant differences between the two groups in the HFUS features (lesion thickness, lesion shape, bottom shape, layer involvement, pseudopodia morphology and colour Doppler blood flow signal; allP < 0.05). The distribution of the pseudopodia morphology types in thein situEMPD and iEMPD groups was as follows: no pseudopodia, 30/72 and 0/13; irregular bottom, 5/72 and 0/13; small sphere, 5/72 and 0/13; short strip, 21/72 and 0/13; long strip, 8/72 and 3/13; vase shape, 3/72 and 3/13; and nodular convex, 0/72 and 7/13 (P < 0.05 for all). The sensitivity and specificity of high‐risk pseudopodia in identifying iEMPD were 100% and 84.7%, respectively.Conclusions: High‐frequency ultrasound provides morphological information regarding EMPD lesions. Risk stratification for pseudopodia can help to distinguish between iEMPD andin situEMPD lesions.


  • Crisaborole: an emerging therapy for prurigo pigmentosa

    by Mingyuan Xu, Nanhui Wu, Qian Du, Zhiyu Zhou, Dan Deng, Yeqiang Liu